Exploring NCATS in-house biomedical data for evidence-based drug repurposing.

Drug repurposing is a strategy for identifying new uses of approved or investigational drugs that are outside the scope of the original medical indication. Even though many repurposed drugs have been found serendipitously in the past, the increasing availability of large volumes of biomedical data h...

Full description

Bibliographic Details
Main Authors:	Fang Liu, Andrew Patt, Chloe Chen, Ruili Huang, Yanji Xu, Ewy A Mathé, Qian Zhu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0289518&type=printable

Exploring NCATS in-house biomedical data for evidence-based drug repurposing by Fang Liu, Andrew Patt, Chloe Chen, Ruili Huang, Yanji Xu, Ewy A. Mathé, Qian Zhu

Published 2024-01-01

Get full text

Article

Exploring NCATS in-house biomedical data for evidence-based drug repurposing.

Exploring NCATS in-house biomedical data for evidence-based drug repurposing by Fang Liu, Andrew Patt, Chloe Chen, Ruili Huang, Yanji Xu, Ewy A. Mathé, Qian Zhu

Similar Items